Objective Narrow band imaging (NBI) is generally considered to be useful for lesion characterization, but not enhanced detection of gastric lesions, because of the dark endoscopic view. We tested whether the new generation of NBI , which is twice as bright as the previous version, would improve detection of premalignant gastric lesions compared with high-definition white light endoscopy (HD-WLE). Patients and methods This was a multicenter prospective randomized study involving five tertiary institutions in the Asia-Pacific region. A total of 579 patients aged older than 50 years who underwent diagnostic upper gastrointestinal endoscopy were randomized to either HD-WLE or NBI. The outcome measurements were detection of intestinal metaplasia (IM), focal gastric lesions, and gastric cancers. Results Focal gastric lesions were detected in 83/286 (29%) and 119/293 patients (40.6%) by HD-WLE and by NBI, respectively (P = 0.003). IM was detected in 22/286 patients (7.7%) by HD-WLE and in 52/293 patients (17.7%) by NBI (P < 0.001). Gastric cancer were found in 7/286 (2.4%) and 3/293 patients (1%) in HD-WLE and NBI groups, respectively (P = 0.189). Conclusion NBI increased the detection rate of IM compared with HD-WLE. Eur rates of FGL in general and specific lesions such as IM and GC by NBI and HD-WLE in a prospective randomized trial.
Introduction
It is recognized that upper gastrointestinal (UGI) endoscopy can miss premalignant and even cancerous lesions in the stomach [1] [2] [3] . This could conceivably be because of the fact that mucosal changes with these lesions are subtle.
Chromoendoscopy has been used routinely in some centers during UGI endoscopy in an attempt to improve mucosal contrast and detect subtle mucosal lesions [4] . However, this is not the norm in most centers because of the inconvenience of dye spray. Narrow band imaging (NBI) (Olympus Co., Tokyo, Japan) facilitates the examination of the mucosal surface without a need for chromoendoscopy. It is based on the principle that the depth of penetration of light is wavelength dependent, with shorter wavelengths resulting in more superficial penetration, that is blue light penetrates most superficially (mucosal imaging) whereas red light penetrates the deepest (submucosal imaging). In NBI, a rotating interference narrow band filter is interposed after the xenon light source such that when the NBI mode is switched on, discrete blue and green wavelengths are used and this improves mucosal surface contrast and facilitates visualization of mucosal details [5] . It has been shown to be useful for differentiation of focal gastric lesions (FGL) such as gastric cancer (GC), adenoma, and intestinal metaplasia (IM), especially when combined with optical magnification [6] [7] [8] [9] [10] . However, it is generally not considered to be useful in increasing detection rates [11] . This may be because of the dark endoscopic view and dimmer images with the earlier NBI systems. The latest NBI system (190-NBI or 290-NBI) provides endoscopic images at least two-fold brighter than the older version and in full high definition. This may possibly increase the detection rate of FGL by enhancing the visibility of the gastric mucosa with brighter NBI images. In addition, although there is no optical magnification, the system has digital magnification and a setting called 'dual or near focus' that allows the user to select between two focus settings to achieve the desired depth of field for optimal observation. The resultant image magnification is mid-way between full optical magnification and digital magnification.
In this study, we hypothesize that the second-generation NBI system would enhance the detection rate of FGL compared with high-definition white light endoscopy (HD-WLE). The primary aim was to compare the detection
Patients
The study period was from January 2012 to October 2013. Inclusion criteria were as follows: (a) individuals aged more than 50 years undergoing diagnostic or screening UGI endoscopy and (b) ability to provide a written consent to trial participation. Exclusion criteria were as follows: (a) presence of active gastrointestinal bleeding; (b) presence of coagulopathy precluding biopsies; and (c) absence of informed consent. This study was carried out in accordance with the principles of the Declaration of Helsinki, ICH Guidelines for Good Clinical Practice and in full conformity with relevant regulations. All patients provided written informed consent for participation in the study. The study protocol was approved by the respective institutional review boards. The study was registered with Clinicaltrials.gov (NCT: NCT01945177).
Randomization
Patients were randomized in a 1 : 1 ratio in blocks of 20 to undergo either NBI or HD-WLE for UGI endoscopy. Individual random sequence was placed in an opaque envelope and kept by an independent research assistant who was not involved in this study. Once informed consent was obtained, the research assistant would disclose the assigned imaging technique (NBI or HD-WLE) to the responsible endoscopist immediately before the procedure.
Endoscopy equipment
The second-generation NBI system [EVIS LUCERA ELITE 290 series (Hong Kong site) or EVIS EXERA III 190 series (other study sites); Olympus Co.] with HD function and dual focus feature, together with a 26-inch full HD monitor (OEV261H; Olympus Co.), was used for the study. For the HD-WLE arm, the white light mode was used. For the NBI arm, the NBI mode was switched on.
Endoscopic procedure
All procedures were performed by experienced endoscopists familiar with image-enhanced endoscopy who used it regularly in clinical practice. For patients randomized to HD-WLE, the examination was performed using white light. For patients randomized to NBI, the NBI mode was switched on before insertion into the stomach. After the gastric examination findings using NBI were recorded, the endoscopist was allowed to re-examine the gastric mucosa using white light, but any additional findings were not recorded in the study data sheet.
Recorded parameters include presence or absence of focal lesions and the suspected diagnosis such as (a) IM; (b) cancer; (c) early cancer; (d) gastric ulcer or erosion; and (e) other focal lesions. The morphology of lesions was described using the Paris classification [12] . Switching from HD-WLE to NBI and vice versa was allowed at the discretion of the endoscopist after the detection of a lesion. Magnification was allowed in both groups. The decision to perform hot/cold biopsies or snaring was left to the endoscopist. Each lesion was retrieved separately for pathologic examination.
Endoscopic diagnosis
IM was diagnosed on HD-WLE on the basis of whitish color change with plaques, patches, or homogeneous discoloration on the gastric mucosa ( Fig. 1 ) [13] . HD-WLE may possibly also visualize the villous pattern. IM was diagnosed on NBI on the basis of criteria such as light blue crest and villous morphology ( Fig. 2) [10, 14] . Early cancer may present on white light endoscopy with varied nonspecific features such as a subtle polypoid protrusion, a superficial plaque, ulcer, depression, or even a mucosal discoloration [15] . Distortions of the mucosal pit pattern and microvascular pattern on NBI have been found to be characteristic [6] . These lesions were correlated with histology.
Outcomes
Recognizing that the incidence rate of cancer may be low from the study populations, the decision was made to use as a surrogate the detection of IM, a known premalignant condition, as the main outcome variable [16] . Secondary outcome variables were the aggregate detection rate of FGL and the detection of GC.
Statistical analysis
Sample-size calculation was based on the following rationale. In a cross-over study that compared the first- generation NBI with WLE in UGI examination, it was found that most focal lesions were because of IM and that after the age of 50 years, the prevalence rate of IM was 36% [17] . In this study, WLE detected IM in 4.4% of cases, whereas NBI detected IM in 16.2% of cases, with the rest detected by systematic biopsies of gastric mucosa. We arbitrarily assumed that HD-WLE increase the detection rate of IM to 10%, while keeping the IM detection rate by NBI to 16.2%. We determine our sample size to detect a 6.2% difference with a power of 80% and a twosided type 1 error of 0.05. A minimum of 464 patients in total were required. Detection rates between both arms were compared using the χ 2 -test or Fisher's exact test. A P value of less than 0.05 was considered to be statistically significant. Using histology as the gold standard, the diagnostic values of HD-WLE and NBI were assessed for sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy. Statistical analysis was carried out using SPSS V.19.0 software for Windows (SPSS Inc., Chicago, Illinois, USA).
Results

Patient characteristics
A total of 600 patients were initially enrolled, but as 21 patients were actually younger than 50 years of age and thus outside recruitment criteria, they were excluded, leaving 579 patients for analysis ( Fig. 3) . Table 1 shows the clinical characteristics of these 579 patients. Both HD-WLE and NBI groups were comparable in terms of demographics and indications for endoscopy. No procedurerelated adverse events occurred.
Detection of lesions
Overall, 377 patients (65.1%) had no focal lesions, 186 patients (32.1%) had one type, and 16 patients (2.8%) had two types of focal lesions. The predominant morphologies of these lesions were 0-Is (61; 10.5%), 0-IIa (40; 6.9%), 0-IIc (31; 5.4%), 0-IIb (22; 3.8%), 0-III (13; 2.2%), and 0-Ip (8; 1.4%). These lesions included IM, fundic gland polyps, hyperplastic polyps, gastric erosions and ulcers, focal gastritis, and cancer.
FGL were detected in 83/286 (29%) by HD-WLE and in 119/293 (40.6%) by NBI (P = 0.003). IM was detected in 22/286 (7.7%) by HD-WLE and in 52/293 (17.7%) by NBI (relative risk: 2.31, 95% confidence interval: 1.44-3.70; P < 0.001). There was no difference in the GC detection rate between both groups [HD-WLE: 7/286 (2.4%), NBI: 3/293 (1%), P = 0.189]. Hyperplastic polyps or fundic gland polyps were detected in 41/286 (14.3%) by HD-WLE and in 36/293 (12.3%) by NBI (P = 0.468). Gastric erosions or ulcers were detected in 8/286 (2.8%) by HD-WLE and in 4/293 (1.4%) by NBI (P = 0.227). No cases of low-grade intraepithelial neoplasia were detected.
Endoscopic correlation with histology
This part of the subanalysis addressed the issue of lesion characterization in terms of IM and malignancy. The results are summarized in Table 2 . In the case of IM, the analysis included patients who underwent random gastric biopsies in the absence of focal lesions. The sensitivity of NBI and HD-WLE for IM was 92.3 and 59.1%, respectively. The specificity of NBI and HD-WLE for IM was .5%, respectively. The sensitivity of NBI and HD-WLE for malignancy was 100 and 28.6%, respectively. In the NBI group, three GCs were detected and diagnosed. In the HD-WLE group, seven lesions that were ultimately confirmed as GC on the basis of histology were detected, but the diagnosis of GC was made endoscopically in only two. The specificity of NBI and HD-WLE for malignancy was 80.9 and 78.9%, respectively. The PPV of NBI and HD-WLE for malignancy was 12 and 11.1%, respectively. The NPV of NBI and HD-WLE for malignancy was 100 and 92.3%, respectively.
Discussion
In this study, overall, more focal lesions, and in particular, a greater proportion of IM cases were detected in the NBI group. There was no difference between both groups in the detection of gastric erosions and ulcers, and hyperplastic polyps and fundic gland polyps. Unlike the case of ulcers and polyps, areas of IM have less obvious morphological features. Thus, the change in color when the NBI mode is switched on will be particularly useful for diagnosis. This is because of the light blue crest appearance on the mucosa surface, which stands out from the surrounding gastric mucosa. Conversely, the effect may be less marked in the context of ulcers and polyps, where the margins of lesions are already well demarcated. Unfortunately, the question of detection of GC cannot be answered as the number of GC cases was too small for any definitive conclusion. However, it remains a theoretical possibility that abnormal microvascular changes in GC may yet allow it to stand out from the surrounding non-neoplastic mucosa, which will also appear dark because of congestion from gastritis. In fact, the results of endoscopic-histological correlation reaffirmed the fact that the ability of NBI to differentiate malignancy from non-malignancy was superior to HD-WLE [9] . The sensitivity for sensitivity of NBI and HD-WLE for malignancy was 100 and 28.6%, respectively. The results of the study are still clinically relevant. Early appropriate diagnosis is crucial. In the context of premalignant conditions such as IM, patients can then be offered the option of endoscopic surveillance in the long term. In addition, when IM is detected during the index endoscopy, one will be prompted to search more vigilantly for any synchronous GC. However, we do acknowledge that the natural history of IM is poorly understood and the evidence for surveillance is considered to be weak. European guidelines recommend yearly surveillance for dysplasia and every 3 years for extensive IM or gastric atrophy [18] . In Asia, GC screening is performed in highrisk populations such as Japan and Korea at 2-yearly intervals [19] . Studies have suggested that patients with severe IM who undergo yearly endoscopy will have increased detection rate of early GC [20, 21] . Thus, it has been suggested that yearly endoscopy should be performed in these patients with a higher risk [22] . In our study protocol, random systematic biopsies in the absence of visible lesions to map out the pattern and extent of gastritis and IM were not mandated for all patients. Thus, we are unable to report on the pattern of IM distribution in our study. However, this does not detract from our study's key findings of increasing the detection rate of IM.
The strengths of this study are that this was a multicenter, randomized study and had a large sample size. This study also reaffirms previous data. Uedo et al. [10] first described how NBI can be used to characterize and differentiate IM from non IM areas in 2006 on the basis of features such as the light blue crest. It was subsequently shown in a prospective tandem study that NBI increased the detection rate of IM compared with WLE [17] . The limitation of cross-over tandem studies is the possibility of recall bias resulting in higher rates of diagnosis as the same area is examined twice. In this study, the randomization in the study design circumvented the issue of recall bias and it clearly showed that the IM detection rate was increased by NBI. The sensitivity of NBI was higher than HD-WLE, although the specificity of both imaging modalities was similar. In the context of differentiation of non-malignant from malignant diseases, the somewhat low PPV is probably a statistical anomaly because of the low number of malignant cases (10) in the study population. The specificity and NPV of both NBI and HD-WLE for nonmalignancy were similarly high.
The role of NBI in lesion detection and characterization has been assessed at other sites such as the esophagus and colon. These studies are mainly based on the older version of NBI. Although the focus of this study is on gastric lesions, it is of relevance to consider these other studies as part of the assessment of the utility of a new technology. In the esophagus, NBI has been shown to increase the detection rate of small cervical inlet patch [23] , detection and diagnosis of esophageal squamous cancer and precancerous lesions [24, 25] , and detection of dysplasia and neoplasia in Barrett's esophagus [26] . In the colon, it did not increase the polyp detection rate compared with HD-WLE [27] , but compared with non HD-WLE, it did increase the detection rate [28] . Its utility at present is more for polyp differentiation [29] [30] [31] . Recently, Leung et al. [32] conducted a randomized trial to determine whether second-generation NBI (190-NBI) would improve adenoma detection compared with HD-WLE. Patients were randomized to either HD-WLE or NBI on withdrawal. After the initial colonoscopy, a repeat colonoscopy using the same imaging modality was performed by the same endoscopist. Both the adenoma and the polyp detection rates were significantly higher in the 190-NBI group compared with the HD-WL group (adenoma: 48.3 vs. 34.4%, P = 0.01; polyps: 61.1 vs. 48.3%, P = 0.02). The mean number of polyps detected per patient was higher in the 190-NBI group (1.49 vs. 1.13%, P = 0.07). This suggested the potential role of the new-generation NBI systems, with its brighter illumination, in lesion detection, unlike the older NBI systems. In both HD-WLE and NBI groups, second-pass colonoscopy showed adenomas that had been initially missed; the miss rates were similar between both groups (21.2 vs. 21.8%, P = 0.90). Although the intent of performing additional tandem endoscopy after randomization was to determine miss rates, this observation objectively highlighted the limitations of study designs that use tandem endoscopy without randomization.
In the stomach, with the old NBI system, the distant images were dark because of a wide lumen and the mucosa being rich in capillaries compared with other parts of the gastrointestinal tract. It was often difficult to adequately screen the entire gastric lumen by NBI. Thus, it was believed that NBI would not be useful for early GC detection [11] . Conversely, magnifying NBI was shown to be useful to distinguish gastric neoplasia from nonneoplasia, on the basis of the appearance of microsurface and microvessel patterns, once a lesion was detected by WLE [6] . It is possible that the second-generation NBI may play some role in GC detection as it is much brighter. Unfortunately, our study could not address this question. Nonetheless, using IM and aggregate of FGL as a surrogate, and combined with the positive study by Leung et al. [32] for colonic adenoma detection, it certainly holds promise. Future studies that compare HD-WLE with NBI should be carried out in high-risk populations and should include higher risk lesions (low-grade and high-grade dysplasia) with GC as a composite endpoint as well as a larger sample size.
We acknowledge the limitations in our study. We did not perform tandem examination after randomization because of the concern of recall bias when the procedure is performed by a single endoscopist. The work flow did not permit a second endoscopist to perform a second examination at the same setting using the alternative imaging. Nonetheless, because patients were randomized to one of two modalities, and both groups were comparable, we believe that this should be adequate. Another limitation is the fact that we did not routinely perform mucosal biopsies for histological assessment in all cases when the endoscopic evaluation was normal (this was left to discretion of the endoscopist), and thus in theory, the false-negative rates may have been higher. Finally, we are not able to address the more clinically relevant issue of GC detection in our study because of the low prevalence rates in our study population. Nonetheless, this study does provide a proof of concept in that the new-generation NBI can possibly improve the detection rate of focal lesions.
We conclude that the second-generation NBI system is promising for the detection of FGL. It increases the detection rate of IM compared with HD-WLE. Further randomized studies to examine its potential in GC screening are warranted.
